Alexander B. Olawaiye, MD, shares how relacorilant’s recent approval might change the treatment landscape for ovarian cancer.
In a review of nearly 2,000 cases involving patients undergoing emergency surgery, factors independently associated with increased risk for ICU admission included advanced age, trauma-related ...
A prospective survey study presented at the 2026 ASCO Annual Meeting highlighted the heterogeneity of patient experiences ...